http://www.minyanville.com/sectors/biotech-pharma/
Post# of 36728
But I HATE what he says in this part, and that's what scares me.
Currently the chatter is mostly a bout marijuana penny stocks. They are not what Harrison is talking about. He says those stocks are very risky and volatile, and he doesn't touch them. But there are some "real" companies generating interest. Harrison cites the cannabinoid prescription medicine company GW Pharmaceuticals ( NASDAQ:GWPH ) as an example. He's not suggesting the stock as a buy or sell, just as an example he's traded in the past. The stock has rallied more than 500% since last summer.
So I guess we're not a real company? So irritating.